The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb; MSD; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Honoraria - Bristol-Myers Squibb; MSD Oncology
Research Funding - MSD Oncology (Inst); Pierre Fabre (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Roche/Genentech; Roche/Genentech
Does body mass index really predict the response to systemic therapies in metastatic melanoma: A multicenter study from the MelBase French National Cohort?
 
Yoann Di Filippo
No Relationships to Disclose
 
Stéphane Dalle
Employment - Sanofi (I)
Stock and Other Ownership Interests - Sanofi (I)
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pierre Fabre
 
Laurent Mortier
No Relationships to Disclose
 
Caroline Dutriaux
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Sophie Dalac
No Relationships to Disclose
 
Marie Thérèse Leccia
No Relationships to Disclose
 
Delphine Legoupil
No Relationships to Disclose
 
Philippe Saiag
Honoraria - Array BioPharma; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Pierre Fabre; Roche; Sanofi/Regeneron
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Pierre Fabre; Roche; Sanofi/Regeneron
Research Funding - Array BioPharma; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Florence Brunet-Possenti
No Relationships to Disclose
 
Jean-Philippe Arnault
Other Relationship - Bristol-Myers Squibb; MSD
 
Eve Maubec
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Pierre Fabre
Research Funding - MSD (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Pierre Fabre; Pierre Fabre
(OPTIONAL) Uncompensated Relationships - MSD Oncology
 
Florence Granel-Brocard
No Relationships to Disclose
 
Julie De Quatrebarbes
Speakers' Bureau - Bristol-Myers Squibb; Janssen-Cilag
Travel, Accommodations, Expenses - BMS Brazil; MSD Oncology
 
Francois Aubin
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Sanofi
 
Thierry Lesimple
Consulting or Advisory Role - MSD; Pierre Fabre
Research Funding - Roche (Inst)
 
Pierre-Emmanuel Stoebner
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Sanofi
 
Wendy Lefevre
No Relationships to Disclose
 
Olivier Dereure
Consulting or Advisory Role - Bristol-Myers Squibb; Genevrier; Kiowa Kirin; Leo Pharma; MSD; Novartis; Pierre Fabre; Recordati
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre; Recordati
 
Celeste Lebbe
Honoraria - Amgen; Bristol-Myers Squibb; Incyte; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
Other Relationship - Avantis Medical Systems
 
Henri Montaudie
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre
Research Funding - Bristol-Myers Squibb (Inst); Leo Pharma (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pierre Fabre